封面
市場調查報告書
商品編碼
1684816

鄰苯二甲醛市場機會、成長動力、產業趨勢分析與 2025 - 2034 年預測

Ortho Phthalaldehyde Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: | 出版商: Global Market Insights Inc. | 英文 310 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球鄰苯二甲醛市場規模達 59 億美元,預計 2025 年至 2034 年的複合年成長率為 5.3%。這種化合物以其卓越的消毒和防腐性能而聞名,在各個行業中發揮關鍵作用。由於其具有很高的殺菌和微生物控制功效,因此被廣泛應用於醫療保健、製藥、研究實驗室和化學領域。由於人們對感染預防意識的增強和衛生標準的嚴格,對有效消毒解決方案的需求不斷增加,市場正在經歷強勁成長。

鄰苯二甲醛市場 - IMG1

生產和供應鏈的投資正在增加,而配方技術的進步正在提高產品效率並確保遵守嚴格的安全和環境法規。人們越來越重視醫療設施和研究環境的衛生,這正在加速其採用,特別是在已開發地區。此外,人們越來越傾向於使用更安全、毒性更小的消毒劑,而不再使用傳統替代品,而是選擇鄰苯二甲醛。業界正積極探索這種多功能化合物的創新應用,進一步加強其市場地位。醫療程序數量的增加、消毒技術的進步以及關鍵領域對可靠消毒解決方案的日益成長的需求也推動了市場的成長。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 59億美元
預測值 100億美元
複合年成長率 5.3%

鄰苯二甲醛液態部分在 2024 年創造 34 億美元,成為多個產業大規模消毒過程的首選。它的穩定性和易用性,加上高效的醫療消毒和較低的毒性,促進了它的廣泛應用。業界青睞液體配方,因為它們能夠快速消除微生物,同時最大程度地減少對環境的影響。雖然粉末形式佔有較小的市場佔有率,但由於需要乾燥配方的利基應用,其需求逐漸增加。這些配方的多功能性確保了它們適用於各種工業應用。

純度等級>=99%的產品在2024年佔據了65.2%的市場佔有率,體現了其在醫療滅菌和蛋白質檢測方面的卓越性能。這些高純度變異因其精確度和可靠性而受到高度重視,特別是在醫院和研究機構等敏感環境中。其極小的殘留污染確保了安全性和有效性,使其成為關鍵應用的首選。同時,純度為 99% 的產品適用於要求不高的應用,這些應用不需要超高純度。對更高純度配方的偏好凸顯了在衛生和準確性不可妥協的領域對可靠的滅菌解決方案的需求日益增加。

2024 年,美國鄰苯二甲醛市場價值達 17 億美元,主要得益於其在醫療保健領域的廣泛應用,尤其是用於醫療器材的消毒。管理感染控制和外科手術的嚴格監管標準正在刺激對這種化合物的需求。製造商正專注於先進的配方,以最佳化功效和安全性,確保符合安全指南。對感染預防的日益重視和高純度鄰苯二甲醛溶液的採用進一步支持了市場擴張。隨著消毒技術的不斷進步和醫療程序的不斷增加,預計未來幾年美國市場將持續成長。

目錄

第 1 章:方法論與範圍

  • 市場範圍和定義
  • 基礎估算與計算
  • 預測計算
  • 資料來源
    • 基本的
    • 次要
      • 付費來源
      • 公共資源

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
    • 影響價值鏈的因素
    • 利潤率分析
    • 中斷
    • 未來展望
    • 製造商
    • 經銷商
  • 供應商概況
  • 利潤率分析
  • 重要新聞及舉措
  • 監管格局
  • 衝擊力
    • 成長動力
      • 增加醫療保健和醫療設施
      • 不斷擴張的製藥業
      • 化學工業用量增加
    • 產業陷阱與挑戰
      • 監管挑戰
  • 成長潛力分析
  • 波特的分析
  • PESTEL 分析

第4章:競爭格局

  • 介紹
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章:市場規模與預測:依形式,2021-2034 年

  • 主要趨勢
  • 液體
  • 粉末

第 6 章:市場規模及預測:依純度,2021-2034 年

  • 主要趨勢
  • <99%
  • ≥99%

第 7 章:市場規模與預測:按應用,2021-2034 年

  • 主要趨勢
  • 醫療消毒
  • 蛋白質檢測
  • 光阻
  • 其他

第 8 章:市場規模與預測:按地區,2021-2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 墨西哥
  • 中東及非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第9章:公司簡介

  • Advanced Sterilization Products
  • Ataman Kimya
  • Garonit Pharmaceutical
  • Lircon
  • MedPurest
  • MP Biomedicals
  • RX Chemicals
  • Sigma-Aldrich
  • TCI America
  • Voda Chemicals
  • VWR International
簡介目錄
Product Code: 7117

The Global Ortho Phthalaldehyde Market reached USD 5.9 billion in 2024 and is projected to grow at a CAGR of 5.3% from 2025 to 2034. This chemical compound, known for its superior disinfectant and antiseptic properties, plays a critical role across various industries. Its widespread use in healthcare, pharmaceuticals, research laboratories, and the chemical sector stems from its high efficacy in sterilization and microbial control. The market is experiencing robust growth due to increasing demand for effective disinfection solutions, driven by heightened awareness of infection prevention and stringent hygiene standards.

Ortho Phthalaldehyde Market - IMG1

Investments in production and supply chains are on the rise, while advancements in formulation techniques are enhancing product efficiency and ensuring compliance with rigorous safety and environmental regulations. The growing emphasis on maintaining hygiene in medical facilities and research environments is accelerating adoption, particularly in developed regions. Additionally, the shift toward safer, less toxic disinfectants is driving a preference for ortho phthalaldehyde over traditional alternatives. Industries are actively exploring innovative applications for this versatile compound, further strengthening its market presence. The market's growth is also supported by the rising number of medical procedures, advancements in disinfection technologies, and the increasing need for reliable sterilization solutions in critical sectors.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$5.9 Billion
Forecast Value$10 Billion
CAGR5.3%

The liquid form segment of ortho phthalaldehyde generated USD 3.4 billion in 2024, making it the preferred choice for large-scale disinfection processes across multiple industries. Its stability and ease of use, combined with high effectiveness in medical sterilization and a lower toxicity profile, contribute to its widespread adoption. Industries favor liquid formulations for their ability to deliver quick microbial elimination with minimal environmental impact. While the powder form holds a smaller market share, its demand is gradually increasing due to niche applications that require dry formulations. The versatility of these formulations ensures their relevance across diverse industrial applications.

Products with a purity level of >=99% accounted for 65.2% of the market share in 2024, reflecting their superior performance in medical sterilization and protein detection. These high-purity variants are highly valued for their precision and reliability, particularly in sensitive environments such as hospitals and research institutions. Their minimal residual contamination ensures safety and efficacy, making them the preferred choice for critical applications. Meanwhile, products with a 99% purity level cater to less demanding applications where ultra-high purity is not essential. The preference for higher purity formulations highlights the increasing demand for dependable sterilization solutions in sectors where hygiene and accuracy are non-negotiable.

The US ortho phthalaldehyde market generated USD 1.7 billion in 2024, driven by its extensive use in healthcare, particularly for sterilizing medical instruments. Stringent regulatory standards governing infection control and surgical procedures are fueling demand for this compound. Manufacturers are focusing on advanced formulations to optimize both efficacy and safety, ensuring compliance with safety guidelines. The growing emphasis on infection prevention and the adoption of high-purity ortho phthalaldehyde solutions are further supporting market expansion. With ongoing advancements in disinfection technology and the increasing number of medical procedures, the US market is expected to witness sustained growth in the coming years.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry synopsis, 2021-2034

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Factor affecting the value chain
    • 3.1.2 Profit margin analysis
    • 3.1.3 Disruptions
    • 3.1.4 Future outlook
    • 3.1.5 Manufacturers
    • 3.1.6 Distributors
  • 3.2 Supplier landscape
  • 3.3 Profit margin analysis
  • 3.4 Key news & initiatives
  • 3.5 Regulatory landscape
  • 3.6 Impact forces
    • 3.6.1 Growth drivers
      • 3.6.1.1 Increased healthcare and medical facilities
      • 3.6.1.2 Expanding pharmaceutical industry
      • 3.6.1.3 Increased chemical industry usage
    • 3.6.2 Industry pitfalls & challenges
      • 3.6.2.1 Regulatory challenges
  • 3.7 Growth potential analysis
  • 3.8 Porter’s analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Form, 2021-2034 (USD Billion, Kilo Tons)

  • 5.1 Key trends
  • 5.2 Liquid
  • 5.3 Powder

Chapter 6 Market Size and Forecast, By Purity, 2021-2034 (USD Billion, Kilo Tons)

  • 6.1 Key trends
  • 6.2 <99%
  • 6.3 ≥99%

Chapter 7 Market Size and Forecast, By Application, 2021-2034 (USD Billion, Kilo Tons)

  • 7.1 Key trends
  • 7.2 Medical disinfection
  • 7.3 Protein detection
  • 7.4 Photoresist
  • 7.5 Others

Chapter 8 Market Size and Forecast, By Region, 2021-2034 (USD Million, Kilo Tons)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 UK
    • 8.3.2 Germany
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Russia
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 South Korea
    • 8.4.5 Australia
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
  • 8.6 MEA
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Advanced Sterilization Products
  • 9.2 Ataman Kimya
  • 9.3 Garonit Pharmaceutical
  • 9.4 Lircon
  • 9.5 MedPurest
  • 9.6 MP Biomedicals
  • 9.7 RX Chemicals
  • 9.8 Sigma-Aldrich
  • 9.9 TCI America
  • 9.10 Voda Chemicals
  • 9.11 VWR International